![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 45/06 | (2006.01) |
A61K 45/06 | (2013.01) | ||
A61K 31/575 | (2006.01) | ||
A61P 1/16 | (2018.01) | ||
A61K 31/4178 | (2006.01) | ||
A61K 31/41 | (2013.01) | ||
A61K 31/41 | (2006.01) | ||
A61K 31/4178 | (2013.01) | ||
A61K 31/4184 | (2006.01) | ||
A61K 31/4184 | (2013.01) | ||
A61K 31/42 | (2006.01) | ||
A61K 31/42 | (2013.01) | ||
A61K 31/4245 | (2006.01) | ||
A61K 31/4245 | (2013.01) | ||
A61K 31/454 | (2006.01) | ||
A61K 31/454 | (2013.01) | ||
A61K 31/46 | (2006.01) | ||
A61K 31/46 | (2013.01) | ||
A61P 1/16 | (2006.01) | ||
A61K 31/575 | (2013.01) |
(11) | Number of the document | 3437659 |
(13) | Kind of document | T |
(96) | European patent application number | 17774971.0 |
Date of filing the European patent application | 2017-03-27 | |
(97) | Date of publication of the European application | 2019-02-06 |
(45) | Date of publication and mention of the grant of the patent | 2023-03-01 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2017/012448 |
Date | 2017-03-27 |
(87) | Number | WO 2017/170434 |
Date | 2017-10-05 |
(30) | Number | Date | Country code |
2016064475 | 2016-03-28 | JP |
(72) |
NAMISAKI, Tadashi , JP
YOSHIJI, Hitoshi , JP
|
(73) |
Intercept Pharmaceuticals, Inc. ,
305 Madison Avenue, Morristown NJ 07960,
US
|
(54) | COMBINATION OF A FXR AGONIST AND AN ANGIOTENSIN II RECEPTOR BLOCKER |
COMBINATION OF A FXR AGONIST AND AN ANGIOTENSIN II RECEPTOR BLOCKER |